In May 2024, the Tandem Mobi insulin pump with Control-IQ technology completed integration with both Dexcom G7 and Dexcom G6 CGM Systems. With this, Tandem Diabetes became the only company that ...

Tandem Diabetes’ t:slim X2 Insulin Pump has received FDA approval for use alongside Dexcom’s G5 Mobile continuous glucose monitoring (CGM) technology. The approval is part of a rapid evolution ...

With this, Tandem Diabetes became the only company that offers two insulin pump options that connect with both Dexcom G6 and Dexcom G7, providing more choices in terms of diabetes management.

To check coverage and start the process of getting a Tandem insulin pump, please visit tandemdiabetes.ca. To learn more about Dexcom G6 or Dexcom G7, please visit dexcom.com or ask your healthcare ...

Today, Benzinga 's options scanner spotted 8 uncommon options trades for DexCom. This isn't normal. The overall sentiment of ...

The FDA announced on Monday that it has cleared Insulet’s Omnipod insulin pump as the first ... made by both Abbott and Dexcom — which is something that Tandem has done as well.

Tandem Diabetes Care (Nasdaq:TNDM) announced today that it received clearance for the use of rapid-acting insulin with its ...

Available Dexcom CGM products include: Dexcom G6 (adults and children 2 years ... Both Dexcom systems can be programmed to ...

DexCom's revised FY24 sales guidance in the Q2 earnings call led to a $18bn valuation reset. Read why I think DXCM stock is a ...

New over-the-counter sensors, an Abbott-Medtronic partnership and Roche’s first CGM are among diabetes technology’s top stories so far in 2024. Check out MedTech Dive’s roundup of the latest news.